Hangzhou AGS Medtech Co (SHSE:688581) ROCE %: 10.56% (As of Mar. 2026)


SHSE:688581 Hangzhou AGS Medtech Co Ltd SHSE:688581
87 GF Score
Price ¥55.70
GF Value ¥74.30
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Hangzhou AGS Medtech Co ROCE %?

Hangzhou AGS Medtech Co SHSE:688581 -0.89% 87 ROCE % is 10.56% as of Mar. 2026. GuruFocus rates SHSE:688581 with a GF Score™ of 87/100 and a GF Value™ of ¥74.30 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Hangzhou AGS Medtech Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 10.56%.

Hangzhou AGS Medtech Co  (SHSE:688581) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Hangzhou AGS Medtech Co ROCE % Related Terms

Hangzhou AGS Medtech Co ROCE % Historical Data

* Premium members only.

The historical data trend for Hangzhou AGS Medtech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou AGS Medtech Co ROCE % Chart

Hangzhou AGS Medtech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only 109.32 45.75 19.42 14.88 10.63

Hangzhou AGS Medtech Co Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.89 13.52 9.72 8.46 10.56
SHSE:688581
87GF Score
Hangzhou AGS Medtech Co Ltd SHSE:688581
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou AGS Medtech Co ROCE % Calculation

Hangzhou AGS Medtech Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=262.154/( ( (2549.778 - 141.988) + (2676.651 - 151.9) )/ 2 )
=262.154/( (2407.79+2524.751)/ 2 )
=262.154/2466.2705
=10.63 %

Hangzhou AGS Medtech Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=269.544/( ( (2676.651 - 151.9) + (2698.221 - 119.387) )/ 2 )
=269.544/( ( 2524.751 + 2578.834 )/ 2 )
=269.544/2551.7925
=10.56 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 10.56% mean?
Hangzhou AGS Medtech Co (SHSE:688581) has a ROCE % of 10.56% as of Mar. 2026.
Is Hangzhou AGS Medtech Co's ROCE % too high?
Hangzhou AGS Medtech Co's current ROCE % is 10.56%. The Medical Devices & Instruments industry median ROCE % is 2.19. Hangzhou AGS Medtech Co's value of 10.56% is 382.2% above this industry median. Overall, Hangzhou AGS Medtech Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou AGS Medtech Co's ROCE % compare to ABT and SYK?
Hangzhou AGS Medtech Co's ROCE % of 10.56% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.19. Hangzhou AGS Medtech Co's value of 10.56% is 382.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.19, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou AGS Medtech Co's current ROCE % of 10.56% is 382.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou AGS Medtech Co's current ROCE % is 10.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou AGS Medtech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou AGS Medtech Co (SHSE:688581) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥74.30, compared to a current price of ¥55.70 — trading 25% below its estimated fair value. The current ROCE % is 10.56% and 382.2% above the Medical Devices & Instruments industry median of 2.19. Hangzhou AGS Medtech Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Hangzhou AGS Medtech Co (SHSE:688581), the current ROCE % is 10.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hangzhou AGS Medtech Co (SHSE:688581) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou AGS Medtech Co stock appears to be undervalued. The current stock price of ¥55.70 is trading 25% below its estimated GF Value™ of ¥74.30. GuruFocus considers Hangzhou AGS Medtech Co to be Modestly Undervalued.

Key valuation signals for SHSE:688581:

  • ROCE %: 10.56%
  • GF Value™: ¥74.30 vs. price of ¥55.70 (25% below fair value)
  • GF Score™: 87/100 with 4 warning signs
  • Industry Position: 382.2% above the Medical Devices & Instruments median

No single metric tells the full story. See the SHSE:688581 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hangzhou AGS Medtech Co Business Description

Address No. 389 Xingzhong Road, Linping District, Zhejiang Province, Hangzhou, CHN, 311199
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and provide patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
87GF Score

Get the complete analysis for SHSE:688581

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥55.70
Price
¥74.30
GF Value